FDA - MM+M - Medical Marketing and Media

FDA

All articles by FDA

What’s ahead for the FDA?
What’s ahead for the FDA?
Lecia Bushak
June 16, 2021
4:28 pm

Beyond its ongoing response to COVID-19, the agency finds itself grappling with questions around leadership and equity.

Biogen clinches first-mover status on disease-modifying Alzheimer’s drug
Biogen clinches first-mover status on disease-modifying Alzheimer’s drug
Marc Iskowitz
June 8, 2021
8:16 am

Aducanumab, approved by the FDA Monday in a historic decision, is expected to become one of the world’s top-selling drugs.

Five things for health marketers to know: Tuesday, May 25, 2021
Five things for health marketers to know: Tuesday, May 25, 2021
Lecia Bushak
May 25, 2021
5:00 am

U.S. COVID cases reach lowest numbers in a year; Optogenetic therapy shows success in treating blind patient; Verastem wins breakthrough therapy designation for ovarian cancer drug.

Sponsored by Calcium: Five things for health marketers to know: Thursday, May 13, 2021
Sponsored by Calcium: Five things for health marketers to know: Thursday, May 13, 2021
Lecia Bushak
May 13, 2021
5:00 am

States prepare to extend vaccination effort to kids; Moderate House Democrats push back against Pelosi’s drug pricing bill; telehealth companies begin lobbying efforts.

Sponsored by Calcium: Five things for health marketers to know: Wednesday, May 12, 2021
Sponsored by Calcium: Five things for health marketers to know: Wednesday, May 12, 2021
Lecia Bushak
May 12, 2021
5:00 am

India’s seven-day COVID average hits record high; FDA authorizes Pfizer vaccine for children aged 12 to 15; gene therapy using AIDS virus shows promise in treating “bubble baby” disease.

With pharma’s achievement obvious, the industry should demand FDA leadership
With pharma’s achievement obvious, the industry should demand FDA leadership
Steve Madden
April 22, 2021
5:00 am

The industry should press the case for the speedy appointment of an FDA commissioner.

Inside the puzzling delay in naming a new FDA commissioner
Inside the puzzling delay in naming a new FDA commissioner
Lecia Bushak
April 14, 2021
4:45 pm

Without a permanent leader, the FDA’s public-health priorities could be imperiled.

First look: FDA, Marvel, FCB partner on anti-vaping comic
First look: FDA, Marvel, FCB partner on anti-vaping comic
MM+M Staff
April 6, 2021
12:30 pm

“The Mind Control Menace” casts addiction as its supervillain.

Five things for health marketers to know: Tuesday, April 6, 2021
Five things for health marketers to know: Tuesday, April 6, 2021
Lecia Bushak
April 6, 2021
5:00 am

U.S. administering an average of 3.1 million COVID-19 vaccine doses per day; FDA rejects Acadia application to expand use of anti-psychosis drug; Johnson & Johnson bets $780 million on flu antiviral conjugate therapies.

Five things for pharma marketers to know: Monday, April 5, 2021
Five things for pharma marketers to know: Monday, April 5, 2021
Lecia Bushak
April 5, 2021
5:00 am

Bristol-Myers Squibb pays $75 million in Medicaid settlement; Pfizer builds sterile injectables plant in Michigan; scientists say it’s still unknown whether vaccinated people can carry the COVID-19 virus.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners